These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12860165)

  • 1. Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2.
    Meneses A; Verastegui E; Barrera JL; de la Garza J; Hadden JW
    Int Immunopharmacol; 2003 Aug; 3(8):1083-91. PubMed ID: 12860165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic findings in patients with head and neck squamous cell carcinoma receiving perilymphatic natural cytokine mixture (IRX-2) prior to surgery.
    Meneses A; Verastegui E; Barrera JL; Zinser J; de la Garza J; Hadden JW
    Arch Pathol Lab Med; 1998 May; 122(5):447-54. PubMed ID: 9593347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck.
    Hadden J; Verastegui E; Barrera JL; Kurman M; Meneses A; Zinser JW; de la Garza J; Hadden E
    Int Immunopharmacol; 2003 Aug; 3(8):1073-81. PubMed ID: 12860164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
    van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
    Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A natural cytokine mixture (IRX-2) and interference with immune suppression induce immune mobilization and regression of head and neck cancer.
    Verastegui E; Barrera JL; Zinser J; Del Rio R; Meneses A; De La Garza J; Hadden JW
    Int J Immunopharmacol; 1997; 19(11-12):619-27. PubMed ID: 9669202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmenting sensitivity to radiation therapy and chemotherapy in oral cancer--a multicenter phase I/II clinical Trial.
    Tímár J; Forster-Horváth C; Lukits J; Döme B; Ladányi A; Remenár E; Kásler M; Bencsik M; Répássy G; Szabó G; Velich N; Suba Z; Elõ J; Balatoni Z; Bajtai A; Chretien P; Talor E
    Laryngoscope; 2003 Dec; 113(12):2206-17. PubMed ID: 14660929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?
    McHam SA; Adelstein DJ; Rybicki LA; Lavertu P; Esclamado RM; Wood BG; Strome M; Carroll MA
    Head Neck; 2003 Oct; 25(10):791-8. PubMed ID: 12966502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
    González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial.
    Barrera JL; Verastegui E; Meneses A; Zinser J; de la Garza J; Hadden JW
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):345-51. PubMed ID: 10722007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma.
    Nieuwenhuis EJ; van der Waal I; Leemans CR; Kummer A; Pijpers R; Castelijns JA; Brakenhoff RH; Snow GB
    Head Neck; 2005 Feb; 27(2):150-8. PubMed ID: 15627261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 1 safety study of an IRX-2 regimen in patients with squamous cell carcinoma of the head and neck.
    Freeman SM; Franco JL; Kenady DE; Baltzer L; Roth Z; Brandwein HJ; Hadden JW
    Am J Clin Oncol; 2011 Apr; 34(2):173-8. PubMed ID: 20539208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodeficiency and cancer: prospects for correction.
    Hadden JW
    Int Immunopharmacol; 2003 Aug; 3(8):1061-71. PubMed ID: 12860163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation.
    Vergeer MR; Doornaert P; Leemans CR; Buter J; Slotman BJ; Langendijk JA
    Radiother Oncol; 2006 Apr; 79(1):39-44. PubMed ID: 16632006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
    Saxon A; Portis J
    Cancer Res; 1977 Apr; 37(4):1154-8. PubMed ID: 300279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma.
    Faustina M; Diba R; Ahmadi MA; Esmaeli B
    Ophthalmology; 2004 Oct; 111(10):1930-2. PubMed ID: 15465559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
    Nakamori M; Iwahashi M; Nakamura M; Yamaue H
    J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.